Literature DB >> 9075668

Glutathione kinetics in normal man and in patients with liver cirrhosis.

G Bianchi1, E Bugianesi, M Ronchi, A Fabbri, M Zoli, G Marchesini.   

Abstract

BACKGROUND/AIMS: The dynamics of glutathione in plasma has always been studied by bolus injections. Data are available suggesting that the low plasma levels of cirrhosis are due to decreased production in glutathione-producing tissues, mainly the liver. We aimed to measure the kinetics of glutathione during controlled steady-state conditions, and to determine the reasons for its reduced plasma levels in advanced cirrhosis.
METHODS: The plasma clearance of glutathione was measured in six control subjects and in ten patients with cirrhosis during a 2-step infusion study, producing steady-state levels approximately 5 and 10 times basal values. The plasma disappearance curve after infusion stop was used to determine the apparent volume of distribution and half-life of glutathione, and the estimated basal appearance rate.
RESULTS: The clearance of glutathione did not reject 1st-order kinetics, i.e., it was concentration-independent, and was nearly doubled in cirrhosis. The half-life of exogenous glutathione was not different, whereas the volume of distribution was larger in cirrhosis, in the same range as extracellular water. The endogenous basal appearance rate of glutathione was reduced by 50%, and correlated with liver function, measured by routine and dynamic tests.
CONCLUSIONS: The data confirm that the primary defect responsible for reduced glutathione in liver disease is a reduced production, possibly related to hepatocyte dysfunction and a block along the pathway of methionine metabolism.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9075668     DOI: 10.1016/s0168-8278(97)80426-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

1.  Antioxidation improves in puberty in normal weight and obese boys, in positive association with exercise-stimulated growth hormone secretion.

Authors:  George Paltoglou; Ioannis G Fatouros; George Valsamakis; Maria Schoina; Alexandra Avloniti; Athanasios Chatzinikolaou; Antonis Kambas; Dimitris Draganidis; Aimilia Mantzou; Maria Papagianni; Christina Kanaka-Gantenbein; George P Chrousos; George Mastorakos
Journal:  Pediatr Res       Date:  2015-05-04       Impact factor: 3.756

Review 2.  Can paracetamol (acetaminophen) be administered to patients with liver impairment?

Authors:  Kelly L Hayward; Elizabeth E Powell; Katharine M Irvine; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2015-12-25       Impact factor: 4.335

3.  Reduced Glutathione Level Promotes Epithelial-Mesenchymal Transition in Lens Epithelial Cells via a Wnt/β-Catenin-Mediated Pathway: Relevance for Cataract Therapy.

Authors:  Zongbo Wei; Jane Caty; Jeremy Whitson; Amy D Zhang; Ramkumar Srinivasagan; Terrance J Kavanagh; Hong Yan; Xingjun Fan
Journal:  Am J Pathol       Date:  2017-08-19       Impact factor: 4.307

4.  Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease.

Authors:  P Ljubuncic; Z Tanne; A Bomzon
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

5.  Alcohol abuse enhances pulmonary edema in acute respiratory distress syndrome.

Authors:  David M Berkowitz; Pajman A Danai; Stephanie Eaton; Marc Moss; Greg S Martin
Journal:  Alcohol Clin Exp Res       Date:  2009-07-01       Impact factor: 3.455

Review 6.  Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.

Authors:  R-M Liu; K A Gaston Pravia
Journal:  Free Radic Biol Med       Date:  2009-10-02       Impact factor: 7.376

7.  Protective effect of L-carnitine and coenzyme Q10 on CCl₄-induced liver injury in rats.

Authors:  Sanaa Ahmed Ali; Lilla Faddah; Ateff Abdel-Baky; Asmaa Bayoumi
Journal:  Sci Pharm       Date:  2010-08-23

8.  Changes of Oxidative Stress, Glutathione, and Its Dependent Antioxidant Enzyme Activities in Patients with Hepatocellular Carcinoma before and after Tumor Resection.

Authors:  Shao-Bin Cheng; Hsiao-Tien Liu; Sin-Yuan Chen; Ping-Ting Lin; Chia-Yu Lai; Yi-Chia Huang
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

9.  Impact of Glutathione and Vitamin B-6 in Cirrhosis Patients: A Randomized Controlled Trial and Follow-Up Study.

Authors:  Chia-Yu Lai; Shao-Bin Cheng; Teng-Yu Lee; Yung-Fang Hsiao; Hsiao-Tien Liu; Yi-Chia Huang
Journal:  Nutrients       Date:  2020-07-03       Impact factor: 5.717

Review 10.  Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis.

Authors:  Rui-Ming Liu; Leena P Desai
Journal:  Redox Biol       Date:  2015-10-10       Impact factor: 11.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.